0Suppliers
21Customers
1Debt Items
0Related Chains

Source-Backed Evidence Depth

Cellyan Biotechnology Co., Ltd (HKPD) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

23Total relationships
1Distinct source URLs
4High confidence
0.667Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Cellyan Biotechnology Co., Ltd Suppliers

No suppliers on recordCellyan Biotechnology Co., Ltd has not yet been matched to upstream suppliers in our database, or is still being processed.

Cellyan Biotechnology Co., Ltd Customers

TickerNameConfidenceEvidence
CAINIAO CAINIAO 92% The customer who accounted for approximately 15.5% and 7.45% of the Company’s total revenues for fiscal years 2024 and 2025, respectively, is CaiNiao.
ALIBABA-GROUP ALIBABA-GROUP 85% ...to Alibaba Group’s online trading platforms and other e-commerce platforms that utilize CaiNiao’s logistics services.
ANNUAL-REPORT-COMPANY ANNUAL-REPORT-COMPANY 62% broadening and diversifying our customer base through targeted sales and marketing efforts, including establishing relationships with additional merchants, online stores, and e-commerce platforms. We…
ATLANTIC-HEALTH-CENTURY-INTERNATIONAL-GROUP-LIMI ATLANTIC-HEALTH-CENTURY-INTERNATIONAL-GROUP-LIMI 62% icient distribution of products to the Company’s customers is an integral component of the Company’s overall business strategy. Disruptions at shipping ports or the closure of roads or imposition of …
CAYMAN-LIMITED CAYMAN-LIMITED 62% icient distribution of products to the Company’s customers is an integral component of the Company’s overall business strategy. Disruptions at shipping ports or the closure of roads or imposition of …
ETERNAL-PROFITS-LIMITED ETERNAL-PROFITS-LIMITED 62% icient distribution of products to the Company’s customers is an integral component of the Company’s overall business strategy. Disruptions at shipping ports or the closure of roads or imposition of …
FAME-OVERSEAS-SUPPLY-CHAIN-LIMITED FAME-OVERSEAS-SUPPLY-CHAIN-LIMITED 62% icient distribution of products to the Company’s customers is an integral component of the Company’s overall business strategy. Disruptions at shipping ports or the closure of roads or imposition of …
HANGZHOU-CO-LTD HANGZHOU-CO-LTD 62% our Hong Kong subsidiary, JCB, which we refer to as the “Supply Chain Services” division and (ii) OTC pharmaceutical cross-border procurement and distribution, primarily conducted through our Hong Ko…
H-K-MEDICAL-COMPANY-LIMITED H-K-MEDICAL-COMPANY-LIMITED 62% sidiary to Yeung Sun Fong (H.K.) Medical Company Limited, an unrelated Hong Kong company, on September 11, 2023. 4.B. Business Overview Overview Our business offering consists of two main categories:…
HONG-KONG-LIMITED HONG-KONG-LIMITED 62% ird party systems, including cloud service providers, to accomplish these tasks. The use and disclosure of such information is regulated at the local and international levels. In some cases, such law…
ISSUANCE-DATE-EXPIRATION-DATE-JOINT-CROSS-BORDER ISSUANCE-DATE-EXPIRATION-DATE-JOINT-CROSS-BORDER 62% broadening and diversifying our customer base through targeted sales and marketing efforts, including establishing relationships with additional merchants, online stores, and e-commerce platforms. We…
JOINT-CROSS-BORDER-LOGISTICS-COMPANY-LIMITED JOINT-CROSS-BORDER-LOGISTICS-COMPANY-LIMITED 62% broadening and diversifying our customer base through targeted sales and marketing efforts, including establishing relationships with additional merchants, online stores, and e-commerce platforms. We…
JOINT-MEDICINE-COMPANY JOINT-MEDICINE-COMPANY 62% broadening and diversifying our customer base through targeted sales and marketing efforts, including establishing relationships with additional merchants, online stores, and e-commerce platforms. We…
JOINT-MEDICINE-COMPANY-JOINT-CROSS-BORDER-LOGIST JOINT-MEDICINE-COMPANY-JOINT-CROSS-BORDER-LOGIST 62% broadening and diversifying our customer base through targeted sales and marketing efforts, including establishing relationships with additional merchants, online stores, and e-commerce platforms. We…
LIVI-BANK-LIMITED LIVI-BANK-LIMITED 62% ird party systems, including cloud service providers, to accomplish these tasks. The use and disclosure of such information is regulated at the local and international levels. In some cases, such law…
N-A-JOINT-MEDICINE-COMPANY-JOINT-CROSS-BORDER-LO N-A-JOINT-MEDICINE-COMPANY-JOINT-CROSS-BORDER-LO 62% broadening and diversifying our customer base through targeted sales and marketing efforts, including establishing relationships with additional merchants, online stores, and e-commerce platforms. We…
PACIFIC-HEALTH-CENTURY-INTERNATIONAL-GROUP-LIMIT PACIFIC-HEALTH-CENTURY-INTERNATIONAL-GROUP-LIMIT 62% icient distribution of products to the Company’s customers is an integral component of the Company’s overall business strategy. Disruptions at shipping ports or the closure of roads or imposition of …
PHOENIX-PHARMACEUTICAL-HOLDINGS-HONG-KONG-LIMITE PHOENIX-PHARMACEUTICAL-HOLDINGS-HONG-KONG-LIMITE 62% 0 years of management experience with a strong network and substantial resources and know-how that grew our company as one of the leading OTC pharmaceutical cross-border e-commerce supply chain compa…
PROFIT-SEEKER-LIMITED PROFIT-SEEKER-LIMITED 62% icient distribution of products to the Company’s customers is an integral component of the Company’s overall business strategy. Disruptions at shipping ports or the closure of roads or imposition of …
UNIVERSAL-HEALTH-INTERNATIONAL-GROUP-HOLDING-LIM UNIVERSAL-HEALTH-INTERNATIONAL-GROUP-HOLDING-LIM 62% 0 years of management experience with a strong network and substantial resources and know-how that grew our company as one of the leading OTC pharmaceutical cross-border e-commerce supply chain compa…
V-ALLIANCE-TECHNOLOGY-SUPPLIES-LIMITED V-ALLIANCE-TECHNOLOGY-SUPPLIES-LIMITED 62% broadening and diversifying our customer base through targeted sales and marketing efforts, including establishing relationships with additional merchants, online stores, and e-commerce platforms. We…

Cellyan Biotechnology Co., Ltd Debt Obligations

InstrumentDescriptionConfidenceEvidence
HKPD-DEBT Debt stack $2.3M 90% Market cache reports total debt of $2.3M.

Cellyan Biotechnology Co., Ltd Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Cellyan Biotechnology Co., Ltd.

Cellyan Biotechnology Co., Ltd Ownership

HolderNameConfidenceEvidence
HKPD-OWNER-STONEX-GROUP-INC StoneX Group Inc. 90% 13F overlay lists StoneX Group Inc. as top holder; 4 tracked holders.

Cellyan Biotechnology Co., Ltd Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.
🔐
HKPD
Unlock HKPD Supply Chain Data
Verified relationships include:
CAINIAOCAINIAOCustomer92%
ALIBABA-GROUPALIBABA-GROUPCustomer85%
+19 more relationships locked
Subscribe — View plans →